These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 227439

  • 1. Effect of heat and glutaraldehyde upon the immunogenicity of Meth A sarcoma cells.
    Price MR, Dennick RG, Law LW.
    Br J Cancer; 1979 Oct; 40(4):663-5. PubMed ID: 227439
    [No Abstract] [Full Text] [Related]

  • 2. Resistance of the Meth A sarcoma-associated rejection antigen to inactivation with glutaraldehyde.
    Price MR, Gerlier D, Law LW.
    Br J Cancer; 1981 Oct; 44(4):584-7. PubMed ID: 6794590
    [No Abstract] [Full Text] [Related]

  • 3. Tumour specific and embryonic antigen expression of chemically induced rat tumours.
    Baldwin RW, Glaves D, Pimm MV, Vose BM.
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):715-28. PubMed ID: 4340543
    [No Abstract] [Full Text] [Related]

  • 4. Induction of resistance to ascites tumor in mice with MFS-180 cells treated with glutaraldehyde, lipopolysaccharide, and concanavalin A.
    Nerkar DP, Chander R, Bandekar JR, Lewis NF.
    Cancer Res; 1981 Jul; 41(7):2922-4. PubMed ID: 6788363
    [Abstract] [Full Text] [Related]

  • 5. Radiation-killed BCG in the treatment of transplanted rat tumours.
    Baldwin RW, Cook AJ, Hopper DG, Pimm MV.
    Int J Cancer; 1974 Jun 15; 13(6):743-50. PubMed ID: 4369104
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of cell-mediated cytotoxicity to chemically induced rat tumours by soluble tumour and embryo cell extracts.
    Zöller M, Price MR, Baldwin RW.
    Int J Cancer; 1976 Jan 15; 17(1):129-37. PubMed ID: 175021
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumor immunoprophylaxis in mice using glutaraldehyde-treated syngeneic tumor cells.
    Frost P, Sanderson CJ.
    Cancer Res; 1975 Oct 15; 35(10):2646-50. PubMed ID: 50879
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A preliminary investigation into the role of immunity in modifying the blood- borne spread of chemically induced rat sarcomas.
    Proctor JW, Rudenstam CM, Alexander P.
    J Natl Cancer Inst; 1974 Dec 15; 53(6):1671-6. PubMed ID: 4373575
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biochemical characterization and biologic activities of 82- and 86-kDa tumor antigens isolated from a methylcholanthrene-induced sarcoma, CII-7.
    DuBois GC, Law LW.
    Int J Cancer; 1986 Jun 15; 37(6):925-31. PubMed ID: 3710621
    [Abstract] [Full Text] [Related]

  • 16. Studies on the microcytotoxicity test. I. Evidence that the effects of normal lymphoid cells on tumour cell growth in microtest plates may be caused by non-immunological modifications of the culture medium.
    Brooks CG, Rees RC, Baldwin RW.
    Int J Cancer; 1976 Dec 15; 18(6):778-86. PubMed ID: 186418
    [Abstract] [Full Text] [Related]

  • 17. Tumor-specific immunogenicity of transplantable chemically induced tumors, as demonstrated by uptake of tritiated thymidine by lymphoid cells from isogenic and F1 hybrid mice.
    Phillips ME.
    J Natl Cancer Inst; 1974 Dec 15; 53(6):1665-70. PubMed ID: 4436867
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.